ID   Hec50Co
AC   CVCL_4Y59
SY   HEC-50CO
DR   cancercelllines; CVCL_4Y59
DR   Cosmic; 1393157
DR   Wikidata; Q54882270
RX   PubMed=11830547;
RX   PubMed=33174010;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=33174010
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,16,17
ST   D5S818: 8
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 20
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2929 ! HEC-50B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 9
//
RX   PubMed=11830547;
RA   Dai D.-H., Wolf D.M., Litman E.S., White M.J., Leslie K.K.;
RT   "Progesterone inhibits human endometrial cancer cell growth and
RT   invasiveness: down-regulation of cellular adhesion molecules through
RT   progesterone B receptors.";
RL   Cancer Res. 62:881-886(2002).
//
RX   PubMed=33174010; DOI=10.3892/ijo.2020.5139;
RA   Devor E.J., Gonzalez-Bosquet J., Thiel K.W., Leslie K.K.;
RT   "Genomic characterization of five commonly used endometrial cancer
RT   cell lines.";
RL   Int. J. Oncol. 57:1348-1357(2020).
//